10,11-Dimethoxy-14,15-didehydrovincanmine






Names

    • 10,11-Dimethoxy-14,15-didehydrovincanmine

Attributes

  • Canonical SMILES

    CC[C@]1([C@]2([H])N3CCC4=C2N([C@@](C(OC)=O)(C1)O)C5=C4C=C(OC)C(OC)=C5)C=CC3[H]

  • InChI

    InChI=1S/C23H28N2O5/c1-5-22-8-6-9-24-10-7-14-15-11-17(28-2)18(29-3)12-16(15)25(19(14)20(22)24)23(27,13-22)21(26)30-4/h6,8,11-12,20,27H,5,7,9-10,13H2,1-4H3/t20-,22+,23+/m1/s1

  • Molecule Class: Alkaloids
  • TPSA: 73.16000000000001
  • #RotBonds: 4
  • MW: 412.48600000000016
  • HBD: 1
  • HBA: 7
  • logP: 2.745700000000001
  • Chemical Formula: C23H28N2O5


Species

    Species Place of Collection NCBI Taxonomy Voucher Specimen
    T. bovina China, Vietnam 3036760 Cai20150423

External Databases


References

  • Vincan- and eburnan-type alkaloids from Tabernaemontana bovina and their hypoglycemic activity. Phytochemistry, 2021 (PMID 34218044).

Compound-Protein Relationships

  • No relationship found

Compound Activities

    • Hypoglycemic

Predicted NMR Spectral Data


Predicted MS Fragmentation Pattern

    N.B.: It is recommended to zoom in on a specific area of an MS plot before hovering on a peak.

Predicted ADMET Properties

    Property Model Name Predicted Value
    Absorption Caco-2 (logPaap) -4.67
    Human Oral Bioavailability 20% Bioavailable
    Human Intestinal Absorption Absorbed
    Madin-Darby Canine Kidney -4.84
    Human Oral Bioavailability 50% Non-Bioavailable
    P-Glycoprotein Inhibitor Non-Inhibitor
    P-Glycoprotein Substrate Substrate
    Skin Permeability -2.37
    Distribution Blood-Brain Barrier (Central Nervous System) -2.97
    Blood-Brain Barrier Penetrable
    Fraction Unbound (Human) 0.9
    Plasma Protein Binding 50.11
    Steady State Volume of Distribution 1.96
    Metabolism Breast Cancer Resistance Protein Non-Inhibitor
    CYP 1A2 Inhibitor Non-Inhibitor
    CYP 1A2 substrate Substrate
    CYP 2C19 Inhibitor Non-Inhibitor
    CYP 2C19 substrate Non-Substrate
    CYP 2C9 Inhibitor Non-Inhibitor
    CYP 2C9 Substrate Non-Substrate
    CYP 2D6 Inhibitor Non-Inhibitor
    CYP 2D6 Substrate Non-Substrate
    CYP 3A4 Inhibitor Inhibitor
    CYP 3A4 Substrate Substrate
    OATP1B1 Non-Inhibitor
    OATP1B3 Non-Inhibitor
    Excretion Clearance 8.24
    Organic Cation Transporter 2 Non-Inhibitor
    Half-Life of Drug Half-Life < 3hs
    Toxicity AMES Mutagenesis Safe
    Avian Safe
    Bee Toxic
    Bioconcentration Factor 0.76
    Biodegradation Safe
    Carcinogenesis Safe
    Crustacean Toxic
    Liver Injury I Safe
    Eye Corrosion Safe
    Eye irritation Safe
    Maximum Tolerated Dose -0.25
    Liver Injury II Toxic
    hERG Blockers Safe
    Daphnia Maga 6.52
    Micronucleos Toxic
    NR-AhR Safe
    NR-AR Safe
    NR-AR-LBD Safe
    NR-Aromatase Safe
    NR-ER Safe
    NR-ER-LBD Safe
    NR-GR Toxic
    NR-PPAR-gamma Safe
    NR-TR Safe
    T. Pyriformis -50.94
    Rat (Acute) 3.08
    Rat (Chronic Oral) 1.76
    Fathead Minnow 4.28
    Respiratory Disease Toxic
    Skin Sensitisation Toxic
    SR-ATAD5 Toxic
    SR-ARE Safe
    SR-HSE Safe
    SR-MMP Safe
    SR-p53 Safe
    General Properties Boiling Point 462.29
    Hydration Free Energy -3.72
    Log(D) at pH=7.4 2.48
    Log(P) 2.23
    Log S -2.51
    Log(Vapor Pressure) -8.27
    Melting Point 203.51
    pKa Acid 8.11
    pKa Basic 6.68